JG
JAZZ icon

Jain Global’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jain Global’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,800
Closed -$2.48M – 1370
2025
Q3 		$2.48M Hold
18,800
– – 0.01% 493
2025
Q2 		$2M Hold
18,800
– – 0.02% 504
2025
Q1 		$2.33M Buy
+18,800
New +$2.45M 0.03% 335

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jain Global's JAZZ Position: Q1 2026 in Review

Jain Global sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 35,375 shares — an estimated $6.01M sold.

Jain Global first reported a position in JAZZ in Q4 2024 and held it in 3 quarters. The position peaked at $7.26M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Jain Global reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 35,375 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.01M.
  • Jain Global first reported a position in Jazz Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Jain Global's Jazz Pharmaceuticals position peaked at $7.26M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.